Our data showed that ATF3 potently promotes growth and invasion, and suppresses apoptosis in keloid fibroblasts via activating TGF-β/Smad pathway, suggesting that ATF3 might serve as a novel therapeutic target for the management of keloid. This evidence concerns the gene ATF3 and keloid.